Consequently, the stromal score, immune score, and ESTIMATE score of colorectal cancer (CRC) tumors were computed, revealing a positive correlation between CDKN2A and the risk score, as well as the presence of stromal cells and immune cells. This evidence concerns the gene CDKN2A and colorectal carcinoma.